phenylephrine has been researched along with Acute-On-Chronic Liver Failure (ACLF) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aller, MÁ; Arias, J; Balfagón, G; Blanco-Rivero, J; Caracuel, L; Funes, T; Llévenes, P; Prieto, I; Sastre, E | 1 |
1 other study(ies) available for phenylephrine and Acute-On-Chronic Liver Failure (ACLF)
| Article | Year |
|---|---|
Acute-on-chronic liver disease enhances phenylephrine-induced endothelial nitric oxide release in rat mesenteric resistance arteries through enhanced PKA, PI3K/AKT and cGMP signalling pathways.
Topics: Acute-On-Chronic Liver Failure; Adrenergic alpha-1 Receptor Antagonists; Animals; Cholestasis; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Hypertension, Portal; Isoquinolines; Liver; Liver Cirrhosis; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phenylephrine; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Sulfonamides; Vasoconstriction | 2019 |